| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mai―12 |
Coupling of SARS-CoV-2 to Amyloid Fibrils and Liquid-Liquid Phase Separation |
Hoang Linh Nguyen, Mai Suan Li |
| 2 |
[GO] |
2025―Mai―12 |
What Can Proteomics Tell us About COVID-19 Infections? Mass Spectrometry as a Tool to Find New Proteins as Biomarkers |
Laís L. Brasil-Oliveira, Pedro F. N. Souza, Carlos R. K. Paier, Maria G. L. Bandeira, Lina C. B. Motta, Raquel C. Montenegro, Maria E. A. de Moraes |
| 3 |
[GO] |
2024―Jan―24 |
Global Emergence of SARS-CoV2 Infection and Scientific Interventions to
Contain its Spread |
Himanshu Ajmera, Sudarshan Singh Lakhawat, Naveen Malik, Akhilesh Kumar, Jasvinder Singh Bhatti, Vikram Kumar, et al. (+4) Himanshu Gogoi, Sunil Kumar Jaswal, Sanjeev Chandel, Pushpender Kumar Sharma |
| 4 |
[GO] |
2023―Aug―17 |
ACE2 receptor: a potential pharmacological target in COVID-19 |
Shiheng Zhu, Yaping Zhu, Shungeng Zhang, Zeguang Wang, Zhi Wang |
| 5 |
[GO] |
2023―Feb―22 |
Evaluation of serum humanin and MOTS-c peptide levels in patients with COVID-19 and healthy subjects |
Ahmet Saracaloglu, Ayşe Özlem Mete, Duran Furkan Ucar, Seniz Demiryürek, Enes Erbagcı, Abdullah Tuncay Demiryürek |
| 6 |
[GO] |
2022―Dez―02 |
Potential Of Angiotensin-(1-7) In Covid-19 Treatment |
Evelyn Mendoza-Torres, Patricia Luna, María Fernanda Pérez, Jairo Castellar, Aileen Chang, Yuliet Montoya, et al. (+2) John Bustamante, Wendy Rosales Rada |
| 7 |
[GO] |
2022―Aug―12 |
SARS-CoV-2 infection and C1-esterase inhibitor: Camouflage pattern and new perspective |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naif A. Jalal, Saeed M Kabrah, Athanasios Alexiou, Gaber El-Saber Batiha |
| 8 |
[GO] |
2022―Jun―28 |
Targeting and Modulation of the Natriuretic Peptide System in Covid-19: A single or double-edged effect? |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-Saber Batiha |
| 9 |
[GO] |
2022―Jun―13 |
Calprotectin: the link between acute lung injury and gastrointestinal injury in Covid-19: Ban or boon |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Marwa S. Al-Niemi, Athanasios Alexiou, Gaber El-Saber Batiha |
| 10 |
[GO] |
2022―Mai―13 |
Covid-19 and L-arginine supplementations: Yet to find the missed key |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-Saber Batiha |
| 11 |
[GO] |
2022―Feb―02 |
Genetic and epigenetic diversity of protein molecules related to SARS-CoV-2 entry: where we are and where we should go Running title: Genetic and epigenetic diversity of protein molecules related to SARS-CoV-2 entry |
Shiheng Zhu, Fei Chen, Xiaoyun Li, Yankun Zhang, Xinqing Wang, Chun Luan |
| 12 |
[GO] |
2022―Jan―28 |
Short Amphiphiles or Micelle Peptides May Help To Fight Against COVID-19 |
Sounik Manna, Trinath Chowdhury, Santi M. Mandal, Sujata Maiti Choudhury |
| 13 |
[GO] |
2021―Sep―17 |
Interactions between ACE2 and SARS-CoV-2 S protein: peptide inhibitors for potential drug developments against COVID-19 |
Miribane Dërmaku-Sopjani, Mentor Sopjani |
| 14 |
[GO] |
2021―Sep―13 |
Diversity in the Accessory Proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV Betacoronaviruses |
Christian Alfredo K. Cruz, Paul Mark B. Medina |
| 15 |
[GO] |
2021―Mrz―23 |
RNA sensors as a mechanism of innate immune evasion among SARS-CoV2, HIV and Nipah viruses |
Dalia Cicily Kattiparambil Dixon, Chameli Ratan, Bhagyalakshmi Nair, Sabitha Mangalath, Rachy Abraham, Lekshmi. R. Nath |
| 16 |
[GO] |
2020―Nov―12 |
Are Hsp90 inhibitors good candidates against Covid-19? |
Carlos H. I. Ramos, Kehinde S. Ayinde |
| 17 |
[GO] |
2020―Sep―21 |
Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy. |
Rajesh Kumar Gupta, Girish R. Apte, Kiran Bharat Lokhande, Satyendra Mishra, Jayanta K. Pal |
| 18 |
[GO] |
2020―Sep―09 |
Fusion protein targeted antiviral peptides: fragment based drug design (FBDD) guided rational design of dipeptides against SARS-CoV-2 |
Sounik Manna, Piyush Baindara, Santi M. Mandal |
